In PCa, genetic changes (e.g., activation mutation or deletion of PIK3CA, Akt1 and PTEN, epigenetic and post-translational modifications) leads to dysregulation of PI3K pathway and hence regulates cancer progression, including PCa [54]. The gene discussed is PTEN; the disease is cancer.